Fresenius SE Research and Development Expenses 2016-2025 | FSNUY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Fresenius SE research and development expenses from 2016 to 2025. Research and development expenses can be defined as an expense arising from studies and product development processes.

Fresenius SE Research and Development Expenses 2016-2025 | FSNUY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Fresenius SE research and development expenses from 2016 to 2025. Research and development expenses can be defined as an expense arising from studies and product development processes.

Related Stocks
Company Name	Market Cap
Quest Diagnostics (DGX)	$18.3B
DaVita (DVA)	$11.2B
Encompass Health (EHC)	$10.4B
Chemed (CHE)	$8.5B
Option Care Health (OPCH)	$5.3B
Elanco Animal Health (ELAN)	$4.2B
RadNet (RDNT)	$3.7B
Amedisys (AMED)	$3B
LifeStance Health (LFST)	$2.6B
Addus HomeCare (ADUS)	$1.8B
Astrana Health (ASTH)	$1.6B
U.S Physical Therapy (USPH)	$1B
Pennant (PNTG)	$907M
Aveanna Healthcare Holdings (AVAH)	$886M
Atai Life Sciences (ATAI)	$294M
Daxor (DXR)	$36M
Ontrak (OTRK)	$6M
MEDIROM Healthcare Technologies (MRM)	$4M
Psychemedics (PMD)	$0M